Search results
Eli Lilly to buy bowel disease drug developer Morphic for $3.2 bln - ET HealthWorld | Pharma
The Economic Times· 6 days agoLondon: Eli Lilly will acquire Morphic Holding for $3.2 billion in cash, the companies said on...
Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal, says report - CNBC TV18
CNBC TV18· 5 days agoLilly counts its IBD drug, Omvoh, among its future growth drivers, besides its blockbuster weight...
Novo Nordisk shares down after analysis finds Lilly drug leads to better weight loss - ET...
The Economic Times· 5 days agoLondon: Shares in Novo Nordisk , maker of the wildly popular obesity drug Wegovy, were down 1.1 per...
Pfizer along witth Eli Lilly and Novo Nordisk, enroute to develop their second generation weight...
CNBC TV18· 2 days agoPfizer plans to move a reworked, once-a-day version of its weight loss pill, danuglipron, into...
Eli Lilly weight loss drug beats Ozempic in head-to-head study - ET HealthWorld | Pharma
The Economic Times· 5 days agoWashington: Patients taking Eli Lilly's new drug Mounjaro achieved significantly greater weight loss...
Lilly bolsters IBD portfolio with $3.2bn Morphic acquisition
Pharmaceutical Technology· 5 days agoEli Lilly has signed a definitive agreement to acquire Morphic Holding for $3.2bn, expanding its...
Lilly to buy Morphic in $3B bet on inflammation drug
BioPharma Dive· 6 days agoThe deal would hand Lilly an experimental pill that could one day rival Takeda's blockbuster medicine Entyvio as a treatment for inflammatory bowel...
Novo’s once-weekly insulin rejected by FDA
BioPharma Dive· 3 days agoThe FDA’s decision to turn back the drugmaker’s new insulin product narrows Novo’s lead in the U.S. over Eli Lilly, which has a similar diabetes...
Pfizer moves forward with once-daily weight loss pill
Clinical Trials Arena· 2 days agoNovo Nordisk currently dominates the space with its GLP-1 agonist drug Wegovy (semaglutide) which...
US FTC to sue drug middlemen over insulin prices, source says - ET HealthWorld
The Economic Times· 3 days agoLondon: The U.S. Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health over...